Geistlich Pharma Ag
Clinical trials sponsored by Geistlich Pharma Ag, explained in plain language.
-
New drug combo takes on tough pancreatic cancer
Disease control OngoingThis early-phase trial tests a new drug called GP-2250 combined with the chemotherapy gemcitabine in people with advanced pancreatic cancer that has worsened after standard treatment. The main goal is to check safety and find the right dose. About 64 adults will take part, and re…
Phase: PHASE1 • Sponsor: Geistlich Pharma AG • Aim: Disease control
Last updated Jun 26, 2026 16:43 UTC
-
New bone graft material could improve spine surgery outcomes
Disease control OngoingThis study is testing a material called Orthoss®, made from granules, to help bones in the spine fuse together after surgery. The trial includes 65 adults with lower back problems like slipped discs or narrowing of the spine canal. Doctors will check if the bones fuse properly an…
Sponsor: Geistlich Pharma AG • Aim: Disease control
Last updated Jun 26, 2026 15:57 UTC